The clinical research industry sees significant advancement as CaRe Clinic, a prominent multi-specialty research organization based in Alberta, Canada, has joined the collaborative super network of hyperCORE International. This strategic alliance marks a notable expansion of hyperCORE's global reach and capabilities in conducting clinical trials across multiple therapeutic areas.
CaRe Clinic brings two state-of-the-art, dedicated research centers serving Calgary and Red Deer, along with the central regions of Alberta. The organization has participated in hundreds of clinical trials across various medical fields including women's health, dermatology, general medicine, vaccines, infectious diseases, and migraine treatments. One of the key strengths contributing to this partnership is CaRe Clinic's extensive patient database, which provides access to a potential patient pool of over 1.8 million individuals through investigators' databases and strong partnerships with affiliated clinics.
Troy Hamilton, Director of Operations at CaRe Clinic, emphasized the partnership's significance, stating that it opens doors for unprecedented collaboration and sharing of best practices across borders, which is crucial for clinical research advancement. The organization aims to highlight Canada's robust clinical research ecosystem on the global stage and contribute to pioneering breakthroughs benefiting patients worldwide. The inclusion of CaRe Clinic into hyperCORE International's network expands the organization's presence in Canada with multiple locations and multi-therapeutic offerings.
hyperCORE International, already an industry leader in providing Phase I-IV clinical trial services, now extends its global footprint across two continents and five countries with more than 120 active research sites. Carlos Orantes, President of hyperCORE and CEO at alliance partner Alcanza Clinical Research, expressed enthusiasm about the partnership, noting it immediately increases hyperCORE's footprint at multiple locations in Canada with multi-therapeutic offerings and adds a solid partner to the team. The collaboration leverages collective strengths, with hyperCORE bringing decades of clinical research experience where alliance partners have completed more than 7,000 studies and evaluated thousands of new drugs and treatments in over 150,000 randomized patients.
This partnership is expected to accelerate clinical research and drug development pace, potentially leading to faster medical treatment breakthroughs across various therapeutic areas. By combining CaRe Clinic's robust patient database and recruitment capabilities with hyperCORE's extensive experience and global network, the alliance addresses pressing clinical trial challenges such as patient recruitment and retention. For the broader medical and pharmaceutical industries, this collaboration signifies a trend toward more integrated, efficient, and globally connected clinical research networks, underscoring international cooperation's importance in advancing medical science and bringing new treatments to patients worldwide more rapidly and effectively.
